Maria Nunez
Medical · Elmhurst, NYNPI 1801133541
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.9% of the total across 1,173 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.7% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $7,840, 3.9 times the $2,031 reported in 2021. Among medical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,173 payments — averaging $20.92 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$3K
- Arcutis Biotherapeutics, Inc.$3K
- Sun Pharmaceutical Industries Inc.$2K
- Johnson & Johnson$2K
- Lilly USA, LLC$2K
- Novartis$1K
- plus $11K from 24 others
What the payments were for
- Consulting fees$7503%
- Travel & lodging$2501%
- Food & beverage$22,79093%
- Education$7443%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 163 | $3,111 |
| Arcutis Biotherapeutics, Inc. | 64 | $2,741 |
| Sun Pharmaceutical Industries Inc. | 107 | $2,359 |
| Johnson & Johnson | 75 | $1,847 |
| Lilly USA, LLC | 93 | $1,616 |
| Novartis | 99 | $1,487 |
| UCB, Inc. | 66 | $1,420 |
| Pfizer | 64 | $1,312 |
| Incyte Corporation | 71 | $1,255 |
| Sanofi | 39 | $1,187 |
| Regeneron Healthcare Solutions, Inc. | 33 | $925 |
| LEO Pharma Inc. | 33 | $869 |
| Dermavant Sciences, Inc. | 47 | $800 |
| E.r. Squibb & Sons, L.L.C. | 49 | $765 |
| Amgen | 30 | $566 |
| Galderma Laboratories, L.p. | 23 | $344 |
| Mayne Pharma Commercial LLC | 32 | $304 |
| Botanix SB Inc | 13 | $295 |
| Organon | 14 | $264 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 11 | $211 |
| VYNE Pharmaceuticals Inc. | 8 | $194 |
| Biofrontera Inc. | 10 | $177 |
| Verrica Pharmaceuticals Inc. | 6 | $149 |
| Strata Skin Sciences, Inc. | 13 | $133 |
| Journey Medical Corporation | 4 | $63 |
| Almirall LLC | 2 | $43 |
| Cipher Pharmaceuticals US LLC | 1 | $36 |
| EPI Health, LLC | 1 | $24 |
| Dermira, Inc. | 1 | $22 |
| Amarin Pharma, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$24,534 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 13 | $49,699 |
| Triamcinolone Acetonide | 146 | $18,837 |
| Tavaborole | 19 | $14,046 |
| Doxycycline Hyclate | 34 | $5,824 |
| Hydrocortisone | 23 | $5,052 |
| Ketoconazole | 61 | $2,508 |
| Metronidazole | 45 | $2,223 |
| Clobetasol Propionate | 43 | $1,855 |
| Clindamycin Phosphate | 27 | $1,800 |
| Tretinoin | 15 | $1,438 |
| Mometasone Furoate | 63 | $1,097 |
| Betamethasone Diprop AugmentedBetamethasone/Propylene Glyc | 18 | $958 |
| Fluocinonide | 17 | $847 |
| Ammonium Lactate | 33 | $767 |
| Ciclopirox | 16 | $584 |
Paid to pharmacies, not to this prescriber.
Other medical in Elmhurst
- Rebecca EllwoodAlbany$565K
- Denisse SerranoCortlandt Manor$255K
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Carl ClarkeBrooklyn$116K
- Maureen ThyneNew York$109K
- Gina FriesRochester$106K
- Ilse StraussSmithtown$87K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.